| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.21 | 0.006 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.18 | 0.009 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |